Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Study of Combination Treatment of Binimetinib and Nivolumab for Advanced V600BRAF Wildtype Melanoma with Innate Anti-PD-1 Resistance

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04375527
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:04.790187+00:00
Published At
2024-12-04T00:00:00+00:00
Record Updated At
2024-12-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Clinical Stage III Cutaneous Melanoma AJCC V8", "Clinical Stage IV Cutaneous Melanoma AJCC V8", "Locally Advanced Cutaneous Melanoma", "Metastatic Cutaneous Melanoma", "Pathologic Stage III Cutaneous Melanoma AJCC V8", "Pathologic Stage IIIA Cutaneous Melanoma AJCC V8", "Pathologic Stage IIIB Cutaneous Melanoma AJCC V8", "Pathologic Stage IIIC Cutaneous Melanoma AJCC V8", "Pathologic Stage IIID Cutaneous Melanoma AJCC V8", "Pathologic Stage IV Cutaneous Melanoma AJCC V8", "Unresectable Cutaneous Melanoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-04"
protocolSection.identificationModule.nctId
"NCT04375527"
protocolSection.identificationModule.officialTitle
"A Phase 2 Study of Combination Treatment of Binimetinib and Nivolumab for Advanced V600BRAF Wildtype Melanoma with Innate Anti-PD-1 Resistance"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Clinical Stage III Cutaneous Melanoma AJCC V8 (protocolSection.conditionsModule.conditions)
  • Clinical Stage IV Cutaneous Melanoma AJCC V8 (protocolSection.conditionsModule.conditions)
  • Locally Advanced Cutaneous Melanoma (protocolSection.conditionsModule.conditions)
  • Metastatic Cutaneous Melanoma (protocolSection.conditionsModule.conditions)
  • Pathologic Stage III Cutaneous Melanoma AJCC V8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIIA Cutaneous Melanoma AJCC V8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC V8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIIC Cutaneous Melanoma AJCC V8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IIID Cutaneous Melanoma AJCC V8 (protocolSection.conditionsModule.conditions)
  • Pathologic Stage IV Cutaneous Melanoma AJCC V8 (protocolSection.conditionsModule.conditions)
  • Unresectable Cutaneous Melanoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.